Versha Banerji

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

Jeff P. Sharman, Miklós Egyed, Wojciech Jurczak et al. · The Lancet · 2020 · 583 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Oncology +8

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

Michael R. Grever, Omar Abdel‐Wahab, Leslie A. Andritsos et al. · Blood · 2016 · 271 citations · Full text

Targeting MTHFD2 in acute myeloid leukemia

Yana Pikman, Alexandre Puissant, Gabriela Alexe et al. · The Journal of Experimental Medicine · 2016 · 155 citations · Full text

Primary Aml Blasts, Hematological Malignancy, Medicine +10

The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia

Versha Banerji, Stacey M. Frumm, Kenneth N. Ross et al. · Journal of Clinical Investigation · 2012 · 104 citations · Full text

Cancer Biology, Tumor Biology, Acute Leukemia +18

On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells

Iris Gehrke, Eric D.J. Bouchard, Sara Beiggi et al. · Clinical Cancer Research · 2014 · 80 citations